GREGORY BAKER: Open Payments
NPI 1205924222 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,212 in 187 payments from 29 companies in 2025. Trend: 2023 $4,098 · 2024 $3,428 · 2025 $4,212
Food & beverage: $4,121Education: $91
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $642 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $573 |
| AstraZeneca Pharmaceuticals LP | 14 | $334 |
| Otsuka America Pharmaceutical, Inc. | 15 | $267 |
| Lundbeck LLC | 15 | $263 |
| PFIZER INC. | 7 | $246 |
| Aimmune Therapeutics, Inc. | 16 | $225 |
| Amgen Inc. | 8 | $206 |
| Merck Sharp & Dohme LLC | 9 | $205 |
| E.R. Squibb & Sons, L.L.C. | 9 | $181 |
Products named: CAPLYTA, UZEDY, REXULTI, ZENPEP, VERQUVO, NURTEC ODT, Repatha, CAMZYOS.
Industry payments across CA — which companies pay providers there.
